The applicability of Fluosol DA 20 as a perfusion fluid was investigated in the isolated limb perfusion of 14 mongrel dogs and its performance compared with that of diluted blood. Control of perfusion parameters permitted a direct comparison of the two perfusion liquids. Muscle tissue, blood and perfusate were analyzed for pH, pO2, pCO2, O2 content, lactate, pyruvate, ATP and creatine phosphate. Due to given experimental conditions, the pH values of the perfusion liquid and muscle tissue were in a slightly acidic range. The oxygen uptake of the perfusion liquids and the oxygenation of tissue was satisfactory, the metabolism of the muscle tissue was not disrupted.
BergmeyerH.U., GawehnK.: Methoden der enzymatischen Analyse, Bd. II, Chemie, Weinheim1974.
4.
ClarkL.C.: Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure.Science, 152, 1755–1756, 1966.
5.
ClarkL.C., MooreR.E., DiverS., MüllerM.L.: A new look at the vapor pressure problem in red cell substitutes.Proc. IVth Internet. Symp. on Perfluorochem. Blood Substit., Kyoto, 55–67, 1978.
6.
CreechO., KrementzE.T., RyanR.F., WinbladJ.N.: Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit.Ann. Surg., 148: 616–632, 1958.
7.
GeyerR.P.: Substitutes for blood and its components.Prog. Clin. Biol. Res., 19: 1–21, 1978.
HildP., PfannkuchF., BeisbarthH., RosslenbroichB., ZscherpeE., de TomaG., KramerD.: Oxygenierbare Blutersatzstoffe (Fluosol DA 20) - Einsatzmöglichkeit in der isolierten Extremitätenperfusion.Acta Chir. Austriaca, Suppl.51: 197–198, 1983.
10.
Ingeman-HansenT., Halkjaer-KristensenJ., HalskovO.: Skeletal muscle phosphagen and lactate concentrations in ishaemic dynamic exercise.Eur. J. Appl. Physiol., 46: 261–270, 1981.
11.
KrementzE.T., KnudsonL.: The effect of increased oxygen tension on the tumoricidal effect of nitrogen mustard.Surgery, 50: 266–273, 1961.
12.
McBrideCh.M.: Melanoma - Introduction.World J. Surg., 3: 251–253, 1979.
13.
MitsunoT., OhyanagiH., NaitoR.: Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA).Vth Int. Symp. on Perfluorochem. Blood Substit., Mainz, 1981.
14.
NaitoR., YokoyamaK.: Perfluorochemical blood substitutes.Technical Information5, The Green Cross Corporation, Osaka, 1978.
15.
OhyanagiH., NishijimaM., UsamiM., NishimatsuS., MatsuiE., SaitohY.: Experimental studies on the possible combined chemotherapy to neoplasma with Fluosol-DA infusion.Prog. Clin. Biol. Res., 122: 315–321, 1983.
16.
Schraffordt-KoopsH., BeekluisH., OldhoffJ., OosterhiusJ.W., van der PloegE., VermegA.: Local recurrence and survival in patients with (Clark level IV/V and over 1.5 mm thickness) stage I malignant melanoma of the extremities after regional perfusion.Cancer, 48: 1952–1957, 1981.
17.
StehlinJ.S., GiovanellaB.C., de IpolyiP.D., AndersonR.F.: Eleven years experience with hyperthermic perfusion for melanoma of the extremities.World J. Surg., 3: 305–307, 1979.
18.
TonakJ.: Die hypertherme Zytostatikaperfusion beim malignen Melanom.Zuckschwerdt, München, 1981.
19.
YokoyamaK., YamanouchiK., OhyanagiH., MitsunoT.: Fate of perfluorochemicals in animals after intravenous injection or hemodilution with their emulsions.Chem. Pharm. Bull., 26: 956–966, 1978.
